Drug intelligence / Profile preview

Alsacare

Development stage: Unknown
Lead developer: MetaneX Life Science
Modality: Small Molecules
Administration: Oral

Overview

Alsacare is a branded generic pharmaceutical formulation marketed by MetaneX Life Science, an Indian pharmaceutical company based in Thane, Maharashtra. It is sold in tablet form as 'Alsacare Tablet'. As a branded generic product, it represents an off-patent pharmaceutical formulation, though its specific active ingredients, molecular targets, and therapeutic indications are not publicly detailed in the company's catalog.

Brand names: Alsacare
Other names: Alsacare Tablet

Beyond the preview

Go deeper on Alsacare.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alsacare.

Explore the full profile